CXCL8 and myocardial infarction: We thus designed this prospective study to further evaluate the predictive value of sIL-2R and IL-8 for future adverse cardiovascular endpoints in MI patients, and compare with current biomarkers reflecting myocardial injury and myocardial inflammation (IL-1β, IL-6, IL-10).